Causal effects of inflammatory cytokines on cardiovascular diseases: Insights from genetic evidence

被引:2
作者
Chen, Yuxiu [1 ]
Zhong, Aifang [2 ]
机构
[1] Guizhou Prov Peoples Hosp, Dept Emergency Med, Guiyang 550002, Guizhou, Peoples R China
[2] Cent South Univ, Xiangya Hosp 2, Dept Emergency Med, Changsha 410011, Hunan, Peoples R China
关键词
Mendelian randomization; Cardiovascular disease; Inflammatory; Causal relationship; Heart failure; HEART-FAILURE; MENDELIAN-RANDOMIZATION; PROGNOSTIC VALUE; MACROPHAGES; MARKERS; ALPHA; MODEL; RISK;
D O I
10.1016/j.heliyon.2024.e35447
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The causal relationship between inflammatory cytokines and cardiovascular diseases (CVDs) has not been fully elucidated. Exploring this relationship between circulating inflammatory cytokines and CVDs is crucial for early clinical diagnosis and effective treatment. Methods and Results: This study investigated the causal relationships between 41 inflammatory cytokines and six CVDs: heart failure (HF), myocardial infarction (MI), unstable angina pectoris (UAP), stable angina pectoris (SAP), valvular heart disease (VHD), and aortic aneurysm (AA), using the Mendelian Randomization (MR) method. The primary analysis employed the inversevariance weighted (IVW) method within MR. Heterogeneity and pleiotropy were assessed through MR-Egger regression and the Q statistic. Strong evidence supported the effect of macrophage inflammatory protein-1 beta (MIP-1 beta) on MI (OR = 1.062, P < 0.001, FDR <0.001). Suggestive evidence showed that the Beta nerve growth factor increased the risk of MI (OR = 1.145, P = 0.025), but the stem cell factor (SCF) demonstrated a potential protective effect against MI (OR = 0.910, P = 0.04). SCF and hepatocyte growth factor (HGF) exhibited potential protective effects against SAP. No inflammatory cytokine was associated with UAP. Monocyte chemotactic protein-1 was linked to an increased risk of VHD (OR = 1.056, P = 0.049). Higher levels of interleukin-13 (IL-13), interferon gamma-induced protein 10 (IP-10), and growthregulated oncogene-alpha were associated with increased susceptibility to HF. Elevated basic fibroblast growth factor (bFGF) levels exhibited protective effects against AA (OR = 0.751, P = 0.038). Reverse MR analyses revealed that AA significantly decreased circulating TNF-related apoptosis-inducing ligand (TRAIL) levels (OR = 0.907, P < 0.001, FDR = 0.01). MI significantly increased circulating IL-12-p70 levels (OR = 1.146, P < 0.001, FDR = 0.014). Suggestive evidence indicated the Causal effects of six CVDs on 17 circulating inflammatory cytokines. Conclusions: This study clarified the causal relationships between specific inflammatory cytokines and six CVDs, providing novel insights and evidence into the genetic involvement of inflammatory cytokines in CVDs. These inflammatory cytokines may be potential biomarkers for early disease diagnosis and treatment evaluation.
引用
收藏
页数:12
相关论文
共 61 条
  • [1] Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors
    Ahola-Olli, Ari V.
    Wurtz, Peter
    Havulinna, Aki S.
    Aalto, Kristiina
    Pitkanen, Niina
    Lehtimaki, Terho
    Kahonen, Mika
    Lyytikainen, Leo-Pekka
    Raitoharju, Emma
    Seppala, Ilkka
    Sarin, Antti-Pekka
    Ripatti, Samuli
    Palotie, Aarne
    Perola, Markus
    Viikari, Jorma S.
    Jalkanen, Sirpa
    Maksimow, Mikael
    Salomaa, Veikko
    Salmi, Marko
    Kettunen, Johannes
    Raitakari, Olli T.
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2017, 100 (01) : 40 - 50
  • [2] Development of a stent capable of the controlled release of basic fibroblast growth factor and argatroban to treat cerebral aneurysms: In vitro experiment and evaluation in a rabbit aneurysm model
    Arai, Daisuke
    Ishii, Akira
    Ikeda, Hiroyuki
    Abekura, Yu
    Nishi, Hidehisa
    Miyamoto, Susumu
    Tabata, Yasuhiko
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2019, 107 (06) : 2185 - 2194
  • [3] Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI [10.1161/CIR.0000000000000659, 10.1161/CIR.0000000000000746]
  • [4] Plasma stem cell factor levels are associated with risk of cardiovascular disease and death
    Bjoerkbacka, H.
    Mattisson, I. Yao
    Wigren, M.
    Melander, O.
    Fredrikson, G. N.
    Bengtsson, E.
    Goncalves, I.
    Almgren, P.
    Lagerstedt, J. O.
    Orho-Melander, M.
    Engstroem, G.
    Nilsson, J.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2017, 282 (06) : 508 - 521
  • [5] Cytokines as prognostic biomarkers in pulmonary arterial hypertension
    Boucly, Athenais
    Tu, Ly
    Guignabert, Christophe
    Rhodes, Christopher
    De Groote, Pascal
    Prevot, Gregoire
    Bergot, Emmanuel
    Bourdin, Arnaud
    Beurnier, Antoine
    Roche, Anne
    Jevnikar, Mitja
    Jais, Xavier
    Montani, David
    Wilkins, Martin R.
    Humbert, Marc
    Sitbon, Olivier
    Savale, Laurent
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (03)
  • [6] Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
    Bowden, Jack
    Smith, George Davey
    Burgess, Stephen
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2015, 44 (02) : 512 - 525
  • [7] Secreted Klotho Attenuates Inflammation-Associated Aortic Valve Fibrosis in Senescence-Accelerated Mice P1
    Chen, Jianglei
    Fan, Jun
    Wang, Shirley
    Sun, Zhongjie
    [J]. HYPERTENSION, 2018, 71 (05) : 877 - +
  • [8] CXC-chemokines, a new group of cytokines in congestive heart failure -: possible role of platelets and monocytes
    Damås, JK
    Gullestad, L
    Ueland, T
    Solum, NO
    Simonsen, S
    Froland, SS
    Aukrust, P
    [J]. CARDIOVASCULAR RESEARCH, 2000, 45 (02) : 428 - 436
  • [9] Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers
    Dhingra, Ravi
    Vasan, Ramachandran S.
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 2017, 27 (02) : 123 - 133
  • [10] TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL
    Di Bartolo, Belinda A.
    Cartland, Sian P.
    Harith, Hanis H.
    Bobryshev, Yuri V.
    Schoppet, Michael
    Kavurma, Mary M.
    [J]. PLOS ONE, 2013, 8 (09):